SCHEMBL19913142

SCHEMBL19913142

CC(C)(C)c1ccc2c(c1)c1cc(C(C)(C)C)ccc1n2-c1cc(C#N)cc(-n2c3ccc(C(C)(C)C)cc3c3cc(C(C)(C)C)ccc32)c1-c1ccncc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 3/20 0.40
CYP19A1 P11511 3/20 0.36
KDM1A O60341 2/20 0.36
CSNK1D P48730 5/20 0.36
CSNK1A1 P48729 2/20 0.36
MAPK14 Q16539 1/20 0.36
CSNK1G2 P78368 4/20 0.33
HPGD P15428 2/20 0.32
ALDH1A1 P00352 2/20 0.32
HSD17B10 Q99714 2/20 0.32
LRRK2 Q5S007 1/20 0.32
RECQL P46063 1/20 0.32
GSK3B P49841 1/20 0.32
LMNA P02545 2/20 0.32
MAPT P10636 2/20 0.32
RAB9A P51151 2/20 0.32
NPC1 O15118 1/20 0.32
TP53 P04637 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913135 0.94 KIF11 (0.37) KIF11CYP19A1KDM1ACSNK1DCSNK1A1
SCHEMBL19913144 0.91 KIF11 (0.39) KIF11CYP19A1KDM1ACSNK1DCSNK1A1
SCHEMBL19909329 0.89 KIF11 (0.40) KIF11CYP19A1CSNK1DCSNK1A1MAPK14
SCHEMBL19913137 0.89 KIF11 (0.36) KIF11CYP19A1KDM1AMAPK14
SCHEMBL19908950 0.85 CSNK1A1 (0.41) CYP19A1CSNK1DCSNK1A1MAPK14LRRK2
SCHEMBL19913157 0.85 KIF11 (0.37) KIF11CYP19A1CSNK1DCSNK1A1MAPK14
SCHEMBL19913136 0.85 MAPK14 (0.37) CYP19A1CSNK1DCSNK1A1MAPK14ALDH1A1
SCHEMBL19908948 0.84 KIF11 (0.37) KIF11CYP19A1CSNK1DCSNK1A1MAPK14
SCHEMBL23348411 0.83 KIF11 (0.36) KIF11KDM1A
SCHEMBL21929232 0.82 KIF11 (0.48) KIF11CYP19A1KDM1ACSNK1DCSNK1G2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 KIF11 3067/4885CYP19A1 2142/4885KDM1A 4725/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 KIF11 3082/4885CYP19A1 3879/4885KDM1A 3920/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 KIF11 3067/4885CYP19A1 2142/4885KDM1A 4725/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.